These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2132 related articles for article (PubMed ID: 8119417)

  • 1. Sphingosine-1-phosphate inhibits extracellular matrix protein-induced haptotactic motility but not adhesion of B16 mouse melanoma cells.
    Sadahira Y; Zheng M; Ruan F; Hakomori S; Igarashi Y
    FEBS Lett; 1994 Feb; 340(1-2):99-103. PubMed ID: 8119417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate.
    Kawa S; Kimura S; Hakomori S; Igarashi Y
    FEBS Lett; 1997 Dec; 420(2-3):196-200. PubMed ID: 9459309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine-1-phosphate inhibits actin nucleation and pseudopodium formation to control cell motility of mouse melanoma cells.
    Yamamura S; Sadahira Y; Ruan F; Hakomori S; Igarashi Y
    FEBS Lett; 1996 Mar; 382(1-2):193-7. PubMed ID: 8612751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine-1-phosphate inhibits haptotactic motility by overproduction of focal adhesion sites in B16 melanoma cells through EDG-induced activation of Rho.
    Yamamura S; Hakomori S; Wada A; Igarashi Y
    Ann N Y Acad Sci; 2000 Apr; 905():301-7. PubMed ID: 10818470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction.
    Bornfeldt KE; Graves LM; Raines EW; Igarashi Y; Wayman G; Yamamura S; Yatomi Y; Sidhu JS; Krebs EG; Hakomori S
    J Cell Biol; 1995 Jul; 130(1):193-206. PubMed ID: 7790372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate regulates melanoma cell motility through a receptor-coupled extracellular action and in a pertussis toxin-insensitive manner.
    Yamamura S; Yatomi Y; Ruan F; Sweeney EA; Hakomori S; Igarashi Y
    Biochemistry; 1997 Sep; 36(35):10751-9. PubMed ID: 9271506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of synthetic sialyl 2-->1 sphingosine and other glycosylsphingosines on the structure and function of the "glycosphingolipid signaling domain (GSD)" in mouse melanoma B16 cells.
    Zhang Y; Iwabuchi K; Nunomura S; Hakomori S
    Biochemistry; 2000 Mar; 39(10):2459-68. PubMed ID: 10704195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness.
    Sadahira Y; Ruan F; Hakomori S; Igarashi Y
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9686-90. PubMed ID: 1409683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate.
    Wang F; Nohara K; Olivera A; Thompson EW; Spiegel S
    Exp Cell Res; 1999 Feb; 247(1):17-28. PubMed ID: 10047444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-phosphate inhibits motility of human breast cancer cells independently of cell surface receptors.
    Wang F; Van Brocklyn JR; Edsall L; Nava VE; Spiegel S
    Cancer Res; 1999 Dec; 59(24):6185-91. PubMed ID: 10626811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mouse B16 melanoma cell motility by sphingosine-1-phosphate.
    Igarashi Y; Sadahira Y; Yamamura S; Hakomori S
    Adv Exp Med Biol; 1997; 400B():693-8. PubMed ID: 9547620
    [No Abstract]   [Full Text] [Related]  

  • 12. Sphingosine-1-phosphate as an intercellular signaling molecule.
    Igarashi Y
    Ann N Y Acad Sci; 1998 Jun; 845():19-31. PubMed ID: 9668340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative inhibitory effect of n,n,n-trimethylsphingosine and sphingosine-1-phosphate, co-incorporated in liposomes, on b16 melanoma cell metastasis - cell-membrane signaling as a target in cancer-therapy .4.
    Park Y; Ruan F; Hakomori S; Igarashi Y
    Int J Oncol; 1995 Sep; 7(3):487-94. PubMed ID: 21552864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells.
    Aznavoorian S; Stracke ML; Krutzsch H; Schiffmann E; Liotta LA
    J Cell Biol; 1990 Apr; 110(4):1427-38. PubMed ID: 2324200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2.
    Ohmori T; Yatomi Y; Osada M; Kazama F; Takafuta T; Ikeda H; Ozaki Y
    Cardiovasc Res; 2003 Apr; 58(1):170-7. PubMed ID: 12667959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine inhibits attachment of murine Lewis lung carcinoma cells to laminin and type IV collagen.
    Inokuchi J; Kumamoto Y; Jimbo M; Shimeno H; Nagamatsu A
    FEBS Lett; 1991 Jul; 286(1-2):39-43. PubMed ID: 1864377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate inhibits migration of RBL-2H3 cells via S1P2: cross-talk between platelets and mast cells.
    Yokoo E; Yatomi Y; Takafuta T; Osada M; Okamoto Y; Ozaki Y
    J Biochem; 2004 Jun; 135(6):673-81. PubMed ID: 15213242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets.
    Yatomi Y; Ruan F; Megidish T; Toyokuni T; Hakomori S; Igarashi Y
    Biochemistry; 1996 Jan; 35(2):626-33. PubMed ID: 8555236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine 1-phosphate formation and intracellular Ca2+ mobilization in human platelets: evaluation with sphingosine kinase inhibitors.
    Yang L; Yatomi Y; Satoh K; Igarashi Y; Ozaki Y
    J Biochem; 1999 Jul; 126(1):84-9. PubMed ID: 10393324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine kinase activity is required for sphingosine-mediated phospholipase D activation in C2C12 myoblasts.
    Meacci E; Cencetti F; Donati C; Nuti F; Becciolini L; Bruni P
    Biochem J; 2004 Aug; 381(Pt 3):655-63. PubMed ID: 15109308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 107.